Growth hormone deficiency and vascular risk

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Clinical Endocrinology

• Publication date

  2002-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1046/J.1365-2265.2002.01559.XPMID 12100064
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Plasma homocysteine is not a major risk factor for vascular disease in growth hormone deficient adults

  2001cited by this paper
• Cardiac mass and function, carotid artery intima-media thickness, and lipoprotein levels in growth hormone-deficient adolescents.

  2001cited by this paper
• Treatment of obesity: need to focus on high risk abdominally obese patients

  2001cited by this paper
• Association between premature mortality and hypopituitarism

  2001cited by this paper
• Coronary risk in growth hormone deficient hypopituitary adults: increased predicted risk is due largely to lipid profile abnormalities

  2001cited by this paper
• Growth hormone induces cellular insulin resistance by uncoupling phosphatidylinositol 3-kinase and its downstream signals in 3T3-L1 adipocytes.

  2001cited by this paper
• A prospective study of 5 years of GH replacement therapy in GH-deficient adults: sustained effects on body composition, bone mass, and metabolic indices.

  2001cited by this paper
• Association between premature mortality and hypopituitarism. West Midlands Prospective Hypopituitary Study Group.

  2001cited by this paper
• Growth hormone and cardiovascular disease: an area in rapid growth.

  2001cited by this paper
• Prevalence of diabetes and impaired glucose tolerance in adult hypopituitarism on low dose oral hydrocortisone replacement therapy

  2001cited by this paper
• Abnormal Vascular Reactivity in Growth Hormone Deficiency

  2001cited by this paper
• Prevalence and incidence of hypopituitarism in an adult Caucasian population in northwestern Spain

  2001cited by this paper
• Growth hormone deficiency and replacement in elderly hypopituitary adults

  2000cited by this paper
• Role of nitric oxide in the vasodilator effect of recombinant human growth hormone in patients with dilated cardiomyopathy.

  2000cited by this paper
• Linking lipoprotein (a) and coronary heart disease

  2000cited by this paper
• Insulin‐like growth factor I administration induces fluid and sodium retention in healthy adults: possible involvement of renin and atrial natriuretic factor

  2000cited by this paper
• Insulin and insulin‐like growth factor‐I cause vasorelaxation in human vessels in vitro

  2000cited by this paper
• GH deficiency in the elderly: the case for GH replacement

  2000cited by this paper
• Time to review policy on contraindications to vaccination.

  2000cited by this paper
• Is Vascular Mortality Increased in Hypopituitarism?

  2000cited by this paper
• Time to review policy on contraindications to vaccination.

  2000cited by this paper
• Effects of Growth Hormone Administration on Inflammatory and Other Cardiovascular Risk Markers in Men with Growth Hormone Deficiency

  2000cited by this paper
• Increase of adhesion molecules, fibrinogen, type‐1 plasminogen activator inhibitor and orosomucoid in growth hormone (GH) deficient adults and their modulation by recombinant human GH replacement

  2000cited by this paper
• Effects of growth hormone administration on inflammatory and other cardiovascular risk markers in men with growth hormone deficiency. A randomized, controlled clinical trial.

  2000cited by this paper
• Treatment of growth hormone deficiency in adults.

  2000cited by this paper
• The effect of GH replacement therapy on endothelial function and oxidative stress in adult growth hormone deficiency.

  2000cited by this paper
• Hypopituitary females have a high incidence of cardiovascular morbidity and an increased prevalence of cardiovascular risk factors.

  2000cited by this paper
• Modulation of cortisol metabolism by low-dose growth hormone replacement in elderly hypopituitary patients.

  2000cited by this paper
• Effects of 7 years of growth hormone replacement therapy in hypopituitary adults.

  2000cited by this paper
• Growth hormone and hexarelin prevent endothelial vasodilator dysfunction in aortic rings of the hypophysectomized rat.

  1999cited by this paper
• Characterization and partial purification of the insulin-like growth factor (IGF)-dependent IGF binding protein-4-specific protease from human fibroblast conditioned media.

  1999cited by this paper
• The incidence of cerebrovascular accidents in patients with pituitary adenoma.

  1999cited by this paper
• Endothelial dysfunction in hypopituitary adults with growth hormone deficiency

  1999cited by this paper
• Growth hormone (GH) and atherosclerosis: changes in morphology and function of major arteries during GH treatment.

  1999cited by this paper
• Long-term effects of growth hormone (GH) on body fluid distribution in GH deficient adults: a four months double blind placebo controlled trial.

  1999cited by this paper
• Predictive value of waist-to-hip ratio on cardiovascular risk events

  1999cited by this paper
• Endothelial function in hypertension: the role of superoxide anion.

  1999cited by this paper
• The growth hormone (GH) response to the arginine plus GH-releasing hormone test is correlated to the severity of lipid profile abnormalities in adult patients with GH deficiency.

  1999cited by this paper
• Growth hormone replacement therapy in adults with growth hormone deficiency improves vascular reactivity

  1999cited by this paper
• Life expectancy following surgery for pituitary tumours

  1999cited by this paper
• Observational study in adult hypopituitary patients with untreated growth hormone deficiency (ODA study). Socio-economic impact and health status. Collaborative ODA (Observational GH Deficiency in Adults) Group.

  1999cited by this paper
• Growth hormone (GH) replacement therapy reduces serum sialic acid concentrations in adults with GH‐deficiency: a double‐blind placebo‐controlled study

  1999cited by this paper
• The effect of growth hormone replacement therapy on cortisol–cortisone interconversion in hypopituitary adults: evidence for growth hormone modulation of extrarenal 11β‐hydroxysteroid dehydrogenase activity

  1998cited by this paper
• Insulin and insulin-like growth factor-I cause coronary vasorelaxation in vitro.

  1998cited by this paper
• Comparison between insulin-induced hypoglycemia and growth hormone (GH)-releasing hormone + arginine as provocative tests for the diagnosis of GH deficiency in adults.

  1998cited by this paper
• Sexual dimorphism in 11 β hydroxysteroid dehydrogenase activity and its relation to fat distribution and insulin sensitivity; a study in hypopituitary subjects

  1998cited by this paper
• Endothelial cells in physiology and in the pathophysiology of vascular disorders.

  1998cited by this paper
• [Can normalization of vascular cytoadhesive activity be explained by the anti-atherosclerosis effect of growth hormone?].

  1998cited by this paper
• HDL‐cholesterol reductions associated with adult growth hormone replacement

  1998cited by this paper
• Growth hormone deficiency and cardiovascular risk.

  1998cited by this paper
• Usefulness of IGF-I assay for the diagnosis of GH deficiency in adults

  1998cited by this paper
• Endothelial Dysfunction: Implications for Therapy of Cardiovascular Diseases

  1998cited by this paper
• Diagnostic and therapeutic uses of growth hormone-releasing substances in adult and elderly subjects.

  1998cited by this paper
• Postoperative prognosis in craniopharyngioma with respect to cardiovascular mortality, survival, and tumor recurrence.

  1998cited by this paper
• IGF-I increases forearm blood flow without increasing forearm glucose uptake.

  1998cited by this paper
• Intense sympathetic nerve activity in adults with hypopituitarism and untreated growth hormone deficiency.

  1998cited by this paper
• Defects of insulin action and skeletal muscle glucose metabolism in growth hormone-deficient adults persist after 24 months of recombinant human growth hormone therapy.

  1998cited by this paper
• Cardiovascular mortality among pituitary insufficient patients

  1998cited by this paper
• Altered lipid pattern explains increased cardiovascular mortality in hypopituitary patients with growth hormone deficiency

  1998cited by this paper
• 10 Diagnostic and therapeutic uses of growth hormone-releasing substances in adult and elderly subjects

  1998cited by this paper
• 1 Growth hormone deficiency and cardiovascular risk

  1998cited by this paper
• Insulin and insulin-like growth factor in normal and pathological cardiovascular physiology.

  1997cited by this paper
• Increased arterial intima-media thickness in childhood-onset growth hormone deficiency.

  1997cited by this paper
• Increased cerebrovascular mortality in patients with hypopituitarism

  1997cited by this paper
• Growth hormone and bile acid synthesis. Key role for the activity of hepatic microsomal cholesterol 7alpha-hydroxylase in the rat.

  1997cited by this paper
• Adult growth hormone (GH)-deficient patients demonstrate heterogeneity between childhood onset and adult onset before and during human GH treatment. Adult Growth Hormone Deficiency Study Group.

  1997cited by this paper
• Inhibitory effect of growth hormone on TNF-alpha secretion and nuclear factor-kappaB translocation in lipopolysaccharide-stimulated human monocytes.

  1997cited by this paper
• Abnormal carotid arterial wall dynamics in symptom-free hypopituitary adults.

  1997cited by this paper
• Insulin resistance in growth hormone-deficient adults: defects in glucose utilization and glycogen synthase activity.

  1996cited by this paper
• The effect of hypopituitarism on life expectancy.

  1996cited by this paper
• An open 36-month study of lipid changes with growth hormone in adults: lipid changes following replacement of growth hormone in adult acquired growth hormone deficiency.

  1996cited by this paper
• Insulin-like growth factor I diminishes in vivo and in vitro vascular contractility: role of vascular nitric oxide.

  1996cited by this paper
• Influence of fibroblast growth factor (bFGF) and insulin-like growth factor (IGF-I) on cytoskeletal and contractile structures and on atrial natriuretic factor (ANF) expression in adult rat ventricular cardiomyocytes in culture.

  1996cited by this paper
• Low density lipoprotein particle size in hypopituitary adults receiving conventional hormone replacement therapy.

  1996cited by this paper
• Soluble L-selectin in peripheral arterial disease: relationship with soluble E-selectin and soluble P-selectin.

  1996cited by this paper
• Mechanism of free fatty acid-induced insulin resistance in humans.

  1996cited by this paper
• A Comparative Study of Six Commercial Lipoprotein(a) Assays in Seventeen Laboratories within the British Isles

  1996cited by this paper
• Nitric oxide may mediate the hemodynamic effects of recombinant growth hormone in patients with acquired growth hormone deficiency. A double-blind, placebo-controlled study.

  1996cited by this paper
• Impaired vascular reactivity in insulin-dependent diabetes mellitus is related to disease duration and low density lipoprotein cholesterol levels.

  1996cited by this paper
• Increased Serum Lipoprotein(a) Concentrations after Growth Hormone (GH) Treatment in Patients with Isolated GH Deficiency

  1996cited by this paper
• Long-term Treatment with Growth Hormone Decreases Plasminogen Activator Inhibitor-1 and Tissue Plasminogen Activator in Growth Hormone-deficient Adults

  1996cited by this paper
• Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group.

  1995cited by this paper
• Growth hormone-deficient adults are insulin-resistant.

  1995cited by this paper
• Cardiovascular function and glucocorticoid replacement in patients with hypopituitarism

  1995cited by this paper
• The effect of low dose recombinant human growth hormone replacement on regional fat distribution, insulin sensitivity, and cardiovascular risk factors in hypopituitary adults.

  1995cited by this paper
• Clinical aspects of growth hormone deficiency in adults.

  1995cited by this paper
• Peripheral glucose metabolism in human hyperprolactinaemia

  1995cited by this paper
• Effect of growth hormone, prolactin and insulin on the release of IL-1 alpha, IFN-gamma and IL-4 by staphylococcal enterotoxin A-stimulated splenocytes.

  1995cited by this paper
• Measuring forearm blood flow and interpreting the responses to drugs and mediators.

  1995cited by this paper
• The effects of short and long-term growth hormone replacement therapy in hypopituitary adults on lipid metabolism and carbohydrate tolerance.

  1995cited by this paper
• Stabile D‐peptide analog of insulin‐like growth factor‐l inhibits smooth muscle cell proliferation after carotid ballooning injury in the rat

  1995cited by this paper
• Noninvasive pulse wave analysis for the early detection of vascular disease.

  1995cited by this paper
• Adipose tissue assessed by magnetic resonance imaging in growth hormone-deficient adults: the effect of growth hormone replacement and a comparison with control subjects.

  1995cited by this paper
• Growth hormone replacement in adults

  1994cited by this paper
• Hypertension and cardiac hypertrophy in growth hormone-deficient rats.

  1994cited by this paper
• Comparison of the effects of growth hormone and insulin-like growth factor I on substrate oxidation and on insulin sensitivity in growth hormone-deficient humans.

  1994cited by this paper
• Cardiovascular and renal effects of growth hormone *

  1994cited by this paper
• High fibrinogen and plasminogen activator inhibitor activity in growth hormone-deficient adults.

  1994cited by this paper
• Endothelial-Dependent Vascular Effects of Insulin and Insulin-Like Growth Factor I in the Perfused Rat Mesenteric Artery and Aortic Ring

  1994cited by this paper
• Carotid intima‐media thickness: correlation with the British Regional Heart Study risk score

  1994cited by this paper

• Long-acting growth hormone in the treatment of children with growth hormone deficiency

  2025cites this paper
• Old woman with Sheehan's syndrome suffered severe hyponatremia following percutaneous coronary intervention: a case report and review of literature

  2024cites this paper
• Sheehan syndrome: Cardiovascular and metabolic comorbidities

  2023cites this paper
• The modulation of platelet function by growth hormone in growth hormone deficient Hypopituitary patients

  2023cites this paper
• Growth Hormone Secretory Capacity Is Associated with Cardiac Morphology and Function in Overweight and Obese Patients: A Controlled, Cross-Sectional Study

  2022cites this paper
• Effects of GH on the Aging Process in Several Organs: Mechanisms of Action

  2022cites this paper
• Metabolic Profile and Echocardiographic Evaluation in Adults with Growth Hormone Deficiency

  2022cites this paper
• Standart diyet ile beslenen ratlarda aralıklı beslenmenin büyüme ve ghrelin hormonu üzerine etkisi

  2022cites this paper
• Disorders Glucose Tolerance in Sheehan ' s Syndrome

  2017cites this paper
• Cardiovascular alterations in adult GH deficiency.

  2017cites this paper
• The effect of growth hormone replacement in patients with hypopituitarism on pituitary tumor recurrence, secondary cancer, and stroke

  2017cites this paper
• Mortality in adults with hypopituitarism: a systematic review and meta-analysis

  2017cites this paper
• Low-dose hydrocortisone replacement is associated with improved arterial stiffness index and blood pressure dynamics in severely adrenocorticotrophin-deficient hypopituitary male patients.

  2016cites this paper
• Lipid Accumulation Product: a Simple and Accurate Index for Predicting Metabolic Syndrome in Patients with Adult Growth Hormone Deficiency

  2016cites this paper
• Growth hormone and the risk of atherosclerosis in growth hormone-deficient children.

  2015cites this paper
• Intracranial Arterial Aneurysmal Disease in ChildhoodIntracranial arterial aneurysms (IAAs) disease

  2015cites this paper
• Age-Induced Endothelial Dysfunction and Intima–Media Thickening

  2015cites this paper
• Effects of Growth Hormone Releasing Hormone Treatment on Fat Redistribution, Cardiovascular Indices and Growth Hormone Secretion in HIV Lipodystrophy Principal Investigator:

  2014cites this paper
• Intracranial Arterial Aneurysmal Disease in Childhood

  2014cites this paper
• Study of the correlation between growth hormone deficiency and serum leptin, adiponectin, and visfatin levels in adults.

  2014cites this paper
• Mechanisms and effects of growth hormone deficiency (due to subarachnoid haemorrhage and traumatic brain injury) on quality of life and regional body composition, and the influence of hormone replacement

  2014cites this paper
• Evaluation of left ventricular mass and function, lipid profile, and insulin resistance in Egyptian children with growth hormone deficiency: A single-center prospective case-control study

  2013cites this paper
• Adult growth hormone deficiency: academic extravagance or real clinical entity for the internist?

  2013cites this paper
• Intracranial arterial aneurysms in children and young adults

  2013cites this paper
• Pre-Weaning Growth Hormone Treatment Reverses Hypertension and Endothelial Dysfunction in Adult Male Offspring of Mothers Undernourished during Pregnancy

  2013influential citation
• Hypertension in Growth Hormone Excess and Deficiency

  2013cites this paper
• Uptodate on GH/IGF-1 axis actions

  2013cites this paper
• The GH/IGF-1 axis in chronic heart failure.

  2013cites this paper
• Metabolic aspects of cardiac arrhythmias

  2012cites this paper
• Overall and cause-specific mortality in GH-deficient adults on GH replacement.

  2012cites this paper
• The Endocrine System and the Heart: A Review

  2011cites this paper
• Long-Term Efficacy and Safety of Two Doses of Growth Hormone in Short Japanese Children Born Small for Gestational Age

  2011cites this paper
• Myths and truths of growth hormone and testosterone therapy in heart failure

  2011cites this paper
• Myths and Truths of Growth Hormone and Testosterone in Heart Failure

  2011cites this paper
• Endocrine parameters and phenotypes of the growth hormone receptor gene disrupted (GHR-/-) mouse.

  2011cites this paper
• Endocrine Aspects of the Metabolic Syndrome

  2011cites this paper
• Growth hormone and the cardiovascular system

  2011cites this paper
• Cardiac Function in GHR–/– Mice

  2011cites this paper
• Update: Systemic Diseases and the Cardiovascular System (II). The endocrine system and the heart: a review.

  2011cites this paper
• IGF-1 levels are significantly correlated with patient-reported measures of sexual function

  2011cites this paper
• The influence of growth hormone replacement on peripheral inflammatory and cardiovascular risk markers in adults with severe growth hormone deficiency.

  2010cites this paper
• Metabolic, cardiovascular, and cerebrovascular outcomes in growth hormone-deficient subjects with previous cushing's disease or non-functioning pituitary adenoma.

  2010cites this paper
• Mortality in patients with pituitary disease.

  2010cites this paper
• Prothrombin time, activated thromboplastin time, fibrinogen, and D-dimer levels, and von Willebrand activity of patients with Sheehan's syndrome and the effect of hormone replacement therapy

  2010cites this paper
• Cardiological aging in SAM model: effect of chronic treatment with growth hormone

  2010cites this paper
• Effects of Short Term Genotropin (rhGH) Subcutaneous Injection on Active Ghrelin Concentration in Rat Plasma, Stomach, Kidney, and Pancreas

  2010cites this paper
• American Association of Clinical Endocrinologists medical guidelines for clinical practice for growth hormone use in growth hormone-deficient adults and transition patients - 2009 update.

  2009cites this paper
• IGF-I replacement therapy in children with congenital IGF-I deficiency (Laron syndrome) maintains heart dimension and function.

  2009cites this paper
• Metabolic co-morbidities revealed in patients with childhood-onset adult GH deficiency after cessation of GH replacement therapy for short stature.

  2008cites this paper
• Registries as a tool in evidence‐based medicine: example of KIMS (Pfizer International Metabolic Database)

  2008cites this paper
• The GH–IGF‐I axis and the cardiovascular system: clinical implications

  2008cites this paper
• Current and future perspectives on recombinant growth hormone for the treatment of obesity

  2008cites this paper
• Growth hormone and aging

  2007cites this paper
• Factors that Affect the Dosing Regimen of Growth Hormone Replacement Therapy in Adults with Growth Hormone Deficiency

  2007cites this paper
• Metabolic risk factors for vascular disease in obstructive sleep apnea: a matched controlled study.

  2007cites this paper
• Endocrine Disorders and the Heart

  2007cites this paper
• Cardiovascular disease, hypertension, dyslipidaemia and obesity in patients with hypothalamic-pituitary disease

  2007cites this paper
• Bone health and cardiovascular risk in hypopituitary patients on complete hormone replacement, including GH

  2007cites this paper
• Growth hormone receptor deficiency in mice results in reduced systolic blood pressure and plasma renin, increased aortic eNOS expression, and altered cardiovascular structure and function.

  2007cites this paper
• Cardiovascular risk in patients with growth hormone deficiency: effects of growth hormone substitution.

  2006cites this paper
• Beginning to end: cardiovascular implications of growth hormone (GH) deficiency and GH therapy.

  2006cites this paper
• Persisting effects on fasting glucose levels and insulin sensitivity after 6 months of discontinuation of a very low‐dose GH therapy in adults with severe GH deficiency

  2006cites this paper
• Effect of short-term therapy with recombinant human growth hormone (GH) on metabolic parameters and preclinical atherosclerotic markers in hypopituitary patients with growth hormone deficiency.

  2006cites this paper
• Improvement of cardiac performance and cardiovascular risk factors in children with GH deficiency after two years of GH replacement therapy: an observational, open, prospective, case-control study.

  2006influential citation
• Understanding and meeting the needs of those using growth hormone injection devices

  2006cites this paper
• Echocardiographic assessment of subclinical left ventricular eccentric hypertrophy in adult-onset GHD patients by geometric remodeling: an observational case-control study

  2006cites this paper
• Antiphospholipid syndrome, hyperhomocysteinaemia and normocalcemic hyperparathyroidism

  2006cites this paper
• Lack of Evidence of Premature Atherosclerosis in Untreated Severe Isolated Growth Hormone Deficiency Due to a GHRH Receptor Mutation

  2006cites this paper
• Growth hormone and its disorders

  2006cites this paper
• Lack of evidence of premature atherosclerosis in untreated severe isolated growth hormone (GH) deficiency due to a GH-releasing hormone receptor mutation.

  2006cites this paper
• Genetic variation at the growth hormone (GH1) and growth hormone receptor (GHR) loci as a risk factor for hypertension and stroke

  2006influential citation
• Effect of Short-term Therapy with Recombinant Human Growth Hormone (GH) on Metabolic Parameters and Preclinical Atherosclerotic Markers in Hypopituitary Patients with Growth Hormone Deficiency

  2006cites this paper
• Metabolic syndrome and growth hormone deficiency in adult survivors of childhood acute lymphoblastic leukemia

  2006cites this paper
• Does a gender-related effect of growth hormone (GH) replacement exist on cardiovascular risk factors, cardiac morphology, and performance and atherosclerosis? Results of a two-year open, prospective study in young adult men and women with severe GH deficiency.

  2005cites this paper
• Abnormal growth hormone secretion : clinical aspects

  2005cites this paper
• Massive cardiac thrombosis in a patient with Sheehan's syndrome.

  2005cites this paper
• Smallness for gestational age is associated with persistent change in insulin-like growth factor I (IGF-I) and the ratio of IGF-I/IGF-binding protein-3 in adulthood.

  2005cites this paper
• Carotid artery intima-media thickness and lipid profile in adults with growth hormone deficiency after long-term growth hormone replacement.

  2005cites this paper
• Links between insulin resistance, inflammation and subclinical macrovascular disease in type 2 diabetes

  2005cites this paper
• Effect of Recombinant Human Growth Hormone Administration on Body Composition and Vascular Function and Structure in Old Male Wistar Rats

  2005influential citation
• Short-term administration of growth hormone (GH) lowers blood pressure by activating eNOS/nitric oxide (NO)-pathway in male hypophysectomized (Hx) rats

  2005cites this paper
• Serum homocysteine concentrations in children with growth hormone (GH) deficiency before and after 12 months GH replacement

  2004cites this paper
• The IGF and IGFBP System in Insulin Resistance and Diabetes Mellitus

  2004cites this paper
• A rare case of adulthood-onset growth hormone deficiency presenting as sporadic, symptomatic hypoglycemia

  2004cites this paper
• Combined dietary and pharmacological weight management in obese hypopituitary patients.

  2004cites this paper
• Advances in Growth Hormone Therapy: A New Registry Tool

  2004cites this paper
• Adult growth hormone deficiency. Metabolic alterations and evaluation of different risk groups.

  2004cites this paper
• Effects of ovariectomy and growth hormone administration on body composition and vascular function and structure in old female rats

  2004cites this paper
• Proinflammatory parameters as CRP and IL-6 do not discriminate between post-PCI cardiac patients with and without exercise-induced ischemia as indicated by Tl-201 myocardial scintigraphy.

  2004cites this paper
• Growth hormone and aging.

  2003cites this paper
• Is caregiving hazardous to one's physical health? A meta-analysis.

  2003cites this paper
• Polymorphism in the Promoter Region of the Insulin-like Growth Factor I Gene Is Related to Carotid Intima-Media Thickness and Aortic Pulse Wave Velocity in Subjects With Hypertension

  2003cites this paper
• Body composition and vascular effects of growth hormone administration in old female rats.

  2003cites this paper
• Why Are Caregivers Expected To Be at Higher Risk for Health Problems Than Noncaregivers ?

  2003cites this paper
• Systemic Diseases and the

  year unknowncites this paper